Close

Articles

Evolving Consumer and Doctor Preferences Driving Changes to Preservative-Free Multidose Eyedropper Market

Ophthalmic health has become a growing concern for many reasons – expanding elderly population, air pollution and urban populations to name a few. Not surprisingly, there’s been a growth in products and therapies designed to help ophthalmic issues. In 2017,...

2019 Trends to Watch For in the Global Clinical Trials Sector

The industry’s pledge to improve the clinical trial experience for participants and investigative sites is taking center stage in 2019. Greenphire’s CEO, Jim Murphy, spoke with World Pharma Today about current trends that will gain momentum this year, and...

Implementing a more structured approach to analytical method development

The adoption of lifecycle management to ensure the quality of pharmaceutical products has been discussed extensively over recent years. The modern concept of method lifecycle management (MLCM) provides a framework for defining the criteria and development of analytical methods, aiming...

Digitalizing drug recalls for improved patient safety

Now that serialization is the pharma supply chain’s established reality, it’s time to accelerate the return on the capital invested in compliance solutions. The “what’s next?” question has been on the minds of many in the industry, including leading pharmaceutical...

Technology transfer for a Good management are keys for considerable experience in transferring aseptic processes and systems

There are many reasons for pharma and biotech companies for a technology transfer: Some need a back-up strategy for risk management to provide an adequate market supply for the patient. For others, there may be a lack of appropriate resources/capacity...

Global Developments in Real-World Evidence

Real-world evidence (RWE) and real-world data (RWD) can ‘generate insights about a medicine’s effectiveness, safety and associated costs,1 and due to the emergence of value-based payments (VBP), the relevance and importance of RWE is being further emphasized across the...

Injecting New Blood into the Life Sciences Innovation Process

Innovation and collaboration are the lifeblood of the life sciences. Without them, both research and business come to a standstill. Knowing this, how do pharmaceutical and biotechnology companies get the blood pumping, communicate their position to the marketplace as well...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read